| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
0.557 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.557 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.557 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.557 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.557 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.557 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.557 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.557 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.557 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.557 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.557 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.557 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
BMX |
IPI00514142 |
0.557 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.557 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.557 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.557 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.557 |
Evidence |
|
| NPR2 |
NPR2, ANPRB: Atrial natriuretic peptide receptor B precursor |
NPPC |
NPPC, CNP2: C-type natriuretic peptide precursor [Contains: CNP-22; CNP-29; CNP- |
0.557 |
Evidence |
|